PPARG and neoplasm: We detected a comparable PPARG mutation rate, 3.1% of the tumors (14/455), but a higher RXRA mutation rate, 6.1% of the tumors (28/455) (Fig. 1a and Supplementary Tables 2 and 3) in these tumor series compared to the previous tumor series analyzed.